Skip to content

News

Ovarian Cancer Research Alliance Rivkin Family SummeRun to be Held in Seward Park in Seattle on July 13 to Support Groundbreaking Ovarian Cancer Research

Ovarian Cancer Research Alliance Rivkin Family SummeRun to be Held in Seward Park in Seattle on July 13 to Support Groundbreaking Ovarian Cancer Research

SEATTLE, WA — July 7, 2025 — Hundreds of runners, walkers, families, and even some four-legged friends will gather at Seward Park on Sunday, July 13, 2025, for the OCRA Rivkin Family SummeRun, raising critical funds for ovarian cancer research. Now entering its fourth decade, this iconic and impactful 5K run/walk has raised over $10 … Continued

The Overview: June 2025

The Overview: June 2025

OCRA Featured in Fortune Article on Surgery That Reduces Ovarian Cancer Risk Ovarian Cancer Research Alliance’s (OCRA) leadership in raising awareness about opportunistic salpingectomy—a simple procedure that can significantly reduce the risk of ovarian cancer—is at the center of a new Fortune article.  The story features a personal perspective from journalist and breast cancer survivor … Continued

OCRA Featured in Fortune on Surgery That Reduces Ovarian Cancer Risk

OCRA Featured in Fortune on Surgery That Reduces Ovarian Cancer Risk

A Fortune article published on June 16, 2025, titled I had one simple surgery to lower my risk of the deadliest cancer for women. Here’s why you probably don’t know about it—but should, highlights an effective but underused way to reduce the risk of ovarian cancer: opportunistic salpingectomy, the removal of the fallopian tubes during another … Continued

Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program

Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program

New collaboration enhances support for gynecologic cancer patients through integrated digital and personalized care New York, NY — [June 11, 2025] — Ovarian Cancer Research Alliance (OCRA), the largest global organization dedicated to advancing ovarian and all gynecologic cancer research and supporting patients and their families, is proud to announce a strategic partnership with Iris by … Continued

The Overview: May 2025

The Overview: May 2025

Global Collaborative Research Push Resonates Across Airwaves The launch of the Global Ovarian Cancer Research Consortium has garnered significant media attention, with coverage appearing on NBC News Radio, FOX 5 Washington D.C., KUNS-TV Seattle, WRC-TV Washington D.C. (NBC), WJFF-FM New York (NPR affiliate), and FemTech Insider, among others. The Consortium’s inaugural initiative is a new AI Accelerator Grant — a … Continued

Global Research Push Resonates Across Airwaves

Global Research Push Resonates Across Airwaves

News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The AI Accelerator Grant will award $1 million in funding, along with $1 million in compute support from Microsoft’s AI for Good Lab, to international research … Continued

New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates

New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates

Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research breakthrough. [May 8, 2025] – Today marks World Ovarian Cancer Day and the launch of the Global Ovarian Cancer Research Consortium — a first-of-its-kind alliance uniting … Continued

OCRA’s Health Equity Research Grant Recipients

OCRA’s Health Equity Research Grant Recipients

In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, part of the $6 million in new research OCRA is funding this year. These grants support research focused on identifying and addressing disparities in ovarian … Continued

OCRA Joins Leading Cancer Organizations in Expressing Profound Concern Over Proposed Elimination of CDC’s Cancer Prevention Division

OCRA Joins Leading Cancer Organizations in Expressing Profound Concern Over Proposed Elimination of CDC’s Cancer Prevention Division

On behalf of the millions of Americans living with cancer and at risk for being diagnosed, as well as health care providers, researchers, advocates, and their communities, we express our profound disappointment and grave concern regarding the proposed elimination of the Centers for Disease Control and Prevention’s Division of Cancer Prevention and Control (DCPC) in … Continued

The Overview: April 2025

The Overview: April 2025

Ovarian Cancer Research Alliance (OCRA) has announced that registration for its International Gynecologic Cancer Conference, taking place online from September 15–17, 2025, will be free for all attendees. This annual online event is designed for anyone impacted by gynecologic cancers — patients, survivors, caregivers, and advocates. You’ll hear from leading researchers and clinicians, connect with others who understand … Continued

OCRA Expands Educational Programming with New Offerings

OCRA Expands Educational Programming with New Offerings

Ovarian Cancer Research Alliance (OCRA) has expanded its educational programming, offering new opportunities for patients and survivors to connect, learn, and stay informed. RoundtablesRoundtables are 90-minute discussions focused on common challenges faced after diagnosis, providing strategies for coping and connection with others who understand. Register for Roundtables. WorkshopsWorkshops are “Ovarian Cancer 101,” providing vital foundational … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.